1. Home
  2. JMM vs CRBU Comparison

JMM vs CRBU Comparison

Compare JMM & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Multi-Market Income Fund (MA)

JMM

Nuveen Multi-Market Income Fund (MA)

N/A

Current Price

$5.50

Market Cap

52.0M

Sector

Finance

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$0.36

Market Cap

48.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JMM
CRBU
Founded
1988
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.0M
48.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JMM
CRBU
Price
$5.50
$0.36
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
8.1K
★ 2.3M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 5.44%
N/A
EPS Growth
N/A
★ 3.64
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$170.62
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.31
$0.36
52 Week High
$6.36
$2.49

Technical Indicators

Market Signals
Indicator
JMM
CRBU
Relative Strength Index (RSI) 44.44 25.04
Support Level $5.37 N/A
Resistance Level $5.89 $0.58
Average True Range (ATR) 0.09 0.04
MACD -0.00 0.02
Stochastic Oscillator 15.34 7.03

Price Performance

Historical Comparison
JMM
CRBU

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: